| Literature DB >> 35510223 |
Miao Han1, Heng Li2, Dan Ke3, Li-Ming Tian4, Yi Hong5, Chong Zhang6, Dai-Zhi Tian6, Long Chen4, Li-Rui Zhan4, Shi-Qin Zong4.
Abstract
Purpose: To study the efficacy of Ba Zhen Tang in delaying skin photoaging and its potential mechanism based on network pharmacology and molecular docking.Entities:
Keywords: Ba Zhen Tang; mechanism; molecular docking; network pharmacology; skin photoaging
Year: 2022 PMID: 35510223 PMCID: PMC9058032 DOI: 10.2147/CCID.S344138
Source DB: PubMed Journal: Clin Cosmet Investig Dermatol ISSN: 1178-7015
Figure 1Flowchart showing the network pharmacology and molecular docking for the investigation of the anti-photoaging effect of Ba Zhen Tang. Cyan box refers to main process, transparent color box refers to database or source of data for the main process, green box refers to the origin of top 10 active components.
Figure 2Ba Zhen Tang-active ingredient-target genes map. The 240 target genes of Ba Zhen Tang were arranged in yellow rectangle in the center. The 122 active components of Ba Zhen Tang were arranged in circle. Color classification of active ingredients: red belongs to 5 common ingredients, including DG and SDH, cyan belongs to BS. Blue belongs to BZ, purplish belongs to CX, Orange belongs to FL, green belongs to GC, brown belongs to RS.
Top 10 Active Ingredients in the Network of Ba Zhen Tang-Active Ingredients-Targets Genes Map
| MOL ID | Compound | Degree | OB% | DL | Medicine |
|---|---|---|---|---|---|
| MOL000422 | Kaempferol | 171 | 41.88 | 0.24 | BS, GC, RS |
| MOL000098 | Quercetin | 145 | 46.43 | 0.28 | GC |
| MOL000358 | Beta-Sitosterol | 105 | 36.91 | 0.75 | BS, DG, RS |
| MOL000449 | Stigmasterol | 90 | 43.83 | 0.76 | DG, RS, SDH |
| MOL003896 | 7-Methoxy-2-Methyl Isoflavone | 38 | 42.56 | 0.2 | GC |
| MOL004328 | Naringenin | 35 | 59.29 | 0.21 | GC |
| MOL000392 | Formononetin | 34 | 69.67 | 0.21 | GC |
| MOL002565 | Medicarpin | 30 | 49.22 | 0.34 | GC |
| MOL000354 | Isorhamnetin | 30 | 49.6 | 0.31 | GC |
| MOL000497 | Licochalcone A | 28 | 40.79 | 0.29 | GC |
60 Key Targets of Ba Zhen Tang for Delaying Skin Photoaging
| Gene Names | Protein Names | Degree |
|---|---|---|
| AKT1 | RAC-alpha serine/threonine-protein kinase | 53 |
| TP53 | Cellular tumor antigen p53 | 50 |
| MAPK3 | Mitogen-activated protein kinase 3 | 48 |
| IL6 | Interleukin-6 | 48 |
| TNF | Tumor necrosis factor | 47 |
| MAPK1 | Mitogen-activated protein kinase 1 | 45 |
| PTGS2 | Prostaglandin G/H synthase 2 | 45 |
| MYC | Myc proto-oncogene protein | 45 |
| CASP3 | Caspase-3 | 44 |
| JUN | Transcription factor AP-1 | 44 |
| MAPK8 | Mitogen-activated protein kinase 8 | 44 |
| VEGFA | Vascular endothelial growth factor A | 42 |
| MMP9 | Matrix metalloproteinase-9 | 41 |
| CAT | Catalase | 40 |
| ESR1 | Estrogen receptor | 40 |
| IL1B | Interleukin-1 beta | 39 |
| EGF | Pro-epidermal growth factor | 39 |
| EGFR | Epidermal growth factor receptor | 39 |
| MAPK14 | Mitogen-activated protein kinase 14 | 38 |
| FOS | Proto-oncogene c-Fos | 38 |
| MMP2 | 72 kDa type IV collagenase | 37 |
| PTEN | Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase | 37 |
| SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | 36 |
| PPARG | Peroxisome proliferator-activated receptor gamma | 35 |
| CASP8 | Caspase-8 | 35 |
| HIF1A | Hypoxia-inducible factor 1-alpha | 35 |
| BCL2L1 | Bcl-2-like protein 1 | 34 |
| CASP9 | Caspase-9 | 33 |
| TGFB1 | Transforming growth factor beta-1 proprotein | 31 |
| SOD1 | Superoxide dismutase | 29 |
| CDKN1A | Cyclin-dependent kinase inhibitor 1 | 29 |
| NFKBIA | NF-kappa-B inhibitor alpha | 28 |
| MMP3 | Stromelysin-1 | 27 |
| MMP1 | Interstitial collagenase | 27 |
| NOS2 | Nitric oxide synthase | 26 |
| MAPK10 | Mitogen-activated protein kinase 10 | 25 |
| NFE2L2 | Nuclear factor erythroid 2-related factor 2 | 24 |
| ESR2 | Estrogen receptor beta | 20 |
| CCNA2 | Cyclin-A2 | 19 |
| PPARA | Peroxisome proliferator-activated receptor alpha | 18 |
| GSR | Glutathione reductase | 18 |
| COL1A1 | Collagen alpha-1(I) chain | 18 |
| BAX | Apoptosis regulator | 17 |
| FASN | Fatty acid synthase | 16 |
| IL1A | Interleukin-1 alpha | 16 |
| ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | 15 |
| RXRA | Retinoic acid receptor RXR-alpha | 14 |
| CTSD | Cathepsin D | 13 |
| CHUK | Inhibitor of nuclear factor kappa-B kinase subunit alpha | 13 |
| ODC1 | Ornithine decarboxylase | 12 |
| BAD | Bcl2-associated agonist of cell death | 12 |
| HSF1 | Heat shock factor protein 1 | 11 |
| COL3A1 | Collagen alpha-1(III) chain | 9 |
| PIK3CG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 7 |
| RXRB | Retinoic acid receptor RXR-beta | 7 |
| CYP1B1 | Cytochrome P450 1B1 | 7 |
| ACACA | Acetyl-CoA carboxylase 1 | 5 |
| XDH | Xanthine dehydrogenase/oxidase | 5 |
| PPARD | Peroxisome proliferator-activated receptor delta | 5 |
| SULT1E1 | Sulfotransferase 1E1 | 2 |
Figure 3PPI network of Ba Zhen Tang against photoaging. (A) The core target PPI network constructed by STRING database. (B) The topology analysis of 60 core target protein networks by Cytoscape and arranged in a ring according to the degree value.
Molecular Docking
| Components | Proteins | Docking Score (-kcal/mol) |
|---|---|---|
| Kaempferol | AKT1 | 6.7 |
| TNF | 6.5 | |
| PTGS2 | 9.3 | |
| CASP3 | 7.2 | |
| JUN | 5.8 | |
| Quercetin | AKT1 | 6.8 |
| TP53 | 7.9 | |
| IL6 | 7.1 | |
| TNF | 7.0 | |
| MAPK1 | 9.3 | |
| PTGS2 | 9.4 | |
| MYC | 6.1 | |
| CASP3 | 7.7 | |
| JUN | 6.0 | |
| Beta-Sitosterol | PTGS2 | 9.5 |
| CASP3 | 7.3 | |
| JUN | 6.5 | |
| Stigmasterol | PTGS2 | 8.1 |
| 7-Methoxy-2-Methyl Isoflavone | PTGS2 | 8.9 |
| Naringenin | AKT1 | 7.0 |
| MAPK3 | 9.1 | |
| MAPK1 | 8.7 | |
| PTGS2 | 9.5 | |
| CASP3 | 7.2 | |
| Formononetin | PTGS2 | 8.9 |
| JUN | 5.6 | |
| Medicarpin | PTGS2 | 8.0 |
| Isorhamnetin | PTGS2 | 8.5 |
| Licochalcone A | MAPK1 | 8.2 |
| PTGS2 | 8.3 |
Figure 6Molecular docking diagram. (A) Kaempferol and PTGS2 form hydrogen bonds at TYR-130, ARG-44, GLY-135, and CYS-36. (B) Quercetin and MAPK1 form hydrogen bonds at MET-106, ASP-104, ASP-109, ASP-165, LYS-52, and LYS-112. (C) Naringenin and MAPK3 form hydrogen bonds at LYS-71, ASN-171, and SER-170.
Figure 7Ba Zhen Tang treatment inhibits cell senescence and p16INK4a expression. (A and B) The senescence of Hacat cells treated with Ba Zhen Tang serum was significantly lower than the control group. Scale bar: 200 μm. (C) Compared with the control group, the expression of p16INK4a was significantly decreased in the Ba Zhen Tang group. ***p < 0.001.
Expression of p16INK4a in HaCaT Cells of Each Experimental Group (± S)
| Group | p16INK4a/GAPDH Protein |
|---|---|
| Control group | 0.42±0.04* |
| Ba Zhen Tang group | 0.16±0.03 |
Note: *Compared with Ba Zhen Tang group, P < 0.05.